Martin-Luther-Universität Halle-Wittenberg

Reagenzgläser auf einem Tablett

Weiteres

Login für Redakteure

Poster 2014

C. V. Simoben, F. Ntie-Kang, L. L.  Lifongo, L. M. Mbaze, W. Sippl. A chemotaxonomy and chemoinformatics analysis of natural products from African flora with anti-cancer like activities. PACN Congress on Biodiversity and Global Challenges: A chemical sciences approach.30.11-02.12.2014, Addis Ababa, Ethiopia

T. Nowak, C. Roessler, M. Pannek, M. Gertz, G. T. T. Nguyen, M. Scharfe, W. Sippl, C. Steegborn, M. Schutkowski. From peptidic substrates to inhibitors of human Sirtuin 5 – small lysine modifications make the difference. 3rd Annual Conference of the International Chemical Biology Society.17.-19.11.2014, San Francisco, USA

F. Ntie-Kang, P. A.. Onguéné, M. Scharfe, L. M. Mbaze, L. C. O. Owono, E. Megnassan, W. Sippl, S. M. N. Efange. ConMedNP: a natural product library from Central African medicinal plants for drug discovery. 2nd International Symposium on Natural Products (RSC Events).23.-25.09.2014,  Cape Town, South Africa

C. Platzer, A. Rohe, M. Schutkowski, W. Sippl, M. Schmidt. A fluorescence polarisation based phospho-Tyrosin Myt1 kinase activity assay. DPhG Annual Meeting 201424. – 26.09.2014 Frankfurt (Main)

T. Nowak, C. Roessler, M. Pannek, M. Gertz, G. T. T. Nguyen, M. Scharfe, W. Sippl, C. Steegborn, M. Schutkowski
From peptidic substrates to inhibitors of human Sirtuin 5 – small lysine modifications make the difference

Epigenetics: From Bench To Bedside COST Conference.
05.-08.05.2014, Athens, Greece

I. Slynko, T. Rumpf, E. Metzger, R. Schüle, M. Jung, W. Sippl.
Targeting posttranslational histone modifications – search for novel PRK1 inhibitors.
Epigenetics: From Bench To Bedside COST Conference.
05.-08.05.2014, Athens, Greece

Karaman B. and Sippl W.
Development and validation of MMGB(-8)SA model for predicting the biological activity of sirtuin inhibitors

2nd International BAU Drug Design Congress 2014
17.-19.04.2014, Istanbul, Turkey

Karaman B. and Sippl W.
Development and validation of MMGB(-8)SA model for predicting the biological activity of sirtuin inhibitors

28th Molecular Modeling Workshop 2014
17.-19.03.2014, Erlangen

T. Uengwetwanit, W. Sippl
Filtering strategies for improved virtual screening of HCV NS5B polymerase inhibitors

28th Molecular modeling workshop 2014
17.-19.03.2014, Erlangen

I. Slynko, T. Rumpf, E. Metzger, R. Schüle, M. Jung, W. Sippl.
Virtual screening of PRK1 inhibitors: ensemble docking, rescoring using binding free energy calculation and QSAR model development.

DPhG-Doktorandentagung 2014
10.-12.03.2014, Bayer HealthCare, Wuppertal

J. Melesina, T. Heimburg, K. Wichapong, M. Schmidt, A. Hauser, C. Romier, R. Pierce, M. Jung, W. Sippl
Homology modeling and structure-based design of inhibitors for histone deacetylases from
parasites
DPhG-Doktorandentagung 2014
10.-12.03.2014, Bayer HealthCare, Wuppertal

Zum Seitenanfang